Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M103364200 on October 4, 2001

J. Biol. Chem., Vol. 276, Issue 50, 47575-47582, December 14, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/50/47575    most recent
M103364200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gregson, H. C.
Right arrow Articles by Yokomori, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gregson, H. C.
Right arrow Articles by Yokomori, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Potential Role for Human Cohesin in Mitotic Spindle Aster Assembly*

Heather C. GregsonDagger , John A. SchmiesingDagger , Jong-Soo KimDagger , Toshiki KobayashiDagger §, Sharleen Zhou, and Kyoko YokomoriDagger ||

From the Dagger  Department of Biological Chemistry, College of Medicine, University of California, Irvine, California 92697-1700 and the  Department of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, California 94720-3202

Received for publication, April 16, 2001, and in revised form, August 30, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The cohesin multiprotein complex containing SMC1, SMC3, Scc3 (SA), and Scc1 (Rad21) is required for sister chromatid cohesion in eukaryotes. Although metazoan cohesin associates with chromosomes and was shown to function in the establishment of sister chromatid cohesion during interphase, the majority of cohesin was found to be off chromosomes and reside in the cytoplasm in metaphase. Despite its dissociation from chromosomes, however, microinjection of an antibody against human SMC1 led to disorganization of the metaphase plate and cell cycle arrest, indicating that human cohesin still plays an important role in metaphase. To address the mitotic function of human cohesin, the subcellular localization of cohesin components was reexamined in human cells. Interestingly, we found that cohesin localizes to the spindle poles during mitosis and interacts with NuMA, a spindle pole-associated factor required for mitotic spindle organization. The interaction with NuMA persists during interphase. Similar to NuMA, a significant amount of cohesin was found to associate with the nuclear matrix. Furthermore, in the absence of cohesin, mitotic spindle asters failed to form in vitro. Our results raise the intriguing possibility that in addition to its well demonstrated function in sister chromatid cohesion, cohesin may be involved in spindle assembly during mitosis.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Proper chromosome segregation in mitosis is essential for the maintenance of chromosome integrity. Sister chromatid cohesion, which ensures the pairing of the two sister chromatids, is a prerequisite for proper chromosome segregation at anaphase. Cohesin is a multiprotein complex required for sister chromatid cohesion in eukaryotes. Cohesin was first characterized in Saccharomyces cerevisiae, which is composed of two structural maintenance of chromosome (SMC)1 family proteins, Smc1p and Smc3p, as well as the non-SMC components Scc1 and Scc3p (Refs.1-3 and see review in Ref. 4). A similar complex was identified in Schizosaccharomyces pombe, Xenopus, and humans (5-7). In S. cerevisiae, cohesin functions in both the establishment and maintenance of sister chromatid cohesion from S phase to metaphase (1, 2). Consistently, cohesin in S. cerevisiae stays associated with chromosomes from the late G1 phase until the onset of anaphase (3). Scc1p is a homolog of Rad21 identified earlier in S. pombe (8). Proteolytic cleavage of Scc1p by the cysteine protease separin, which is indirectly promoted by the anaphase-promoting complex at the end of metaphase, is responsible for the destruction of cohesin and the initiation of sister chromatid segregation in anaphase (9). A similar observation was made in S. pombe, although S. pombe cohesin stays associated with chromosomes throughout the cell cycle (7). Studies of S. cerevisiae identified the in vivo binding sites of cohesin on the chromosome arms at estimated intervals of 13 kb with the highest concentration at the centromeric regions (10-12). Similar centromeric clustering of cohesin was also observed in S. pombe (7).

In metazoans, the protein composition of cohesin is conserved, although there are two Scc3p homologs, stromal antigen 1 (SA1) and 2 (SA2), forming separate cohesin complexes in the cell (5, 6). Interestingly, chromosomal association of cohesin in metazoans differs from that of yeast cohesin. In a Xenopus oocyte cell-free system, depletion of cohesin during interphase prior to entering mitosis inhibited subsequent mitotic cohesion of sister chromatids, suggesting that the complex is required for establishing cohesion following DNA replication (13). In contrast to S. cerevisiae, however, metazoan cohesin was found to dissociate from chromosomes prior to entering mitosis (6, 13, 14). Therefore, it is unclear how sister chromatid cohesion is maintained during metaphase. A recent study using Myc-tagged human RAD21 (hRAD21/Scc1) suggested that at least a small amount of hRAD21 is in the centromeric regions during metaphase and is subject to a similar proteolytic cleavage as in yeast (15). Similar localization was reported with the endogenous hRAD21 protein (16). In Xenopus, SA1 was shown to localize between two sister chromatids in vitro, suggesting that a low amount of cohesin may continue to associate with metaphase chromosomes in higher eukaryotes, reminiscent of buttons on a jacket securing a few critical regions of sister chromatids together (5). It was reasoned that the chromosomes of higher eukaryotes must condense to a higher level and that the presence of too many cohesin molecules may interfere with efficient chromosome condensation. However, the observed localization represents a very minor population of cohesin (estimated to be ~5%) (5), and the role of metazoan cohesin in metaphase cohesion has not been clearly demonstrated. Furthermore, it is not known whether cytoplasmic cohesin plays any role in mitosis.

Despite the fact that the majority of cohesin is in the cytoplasm in mitotic cells, we previously showed that the injection of an antibody specific for hSMC1 into human mitotic cells blocked the progression of metaphase and led to disorganization of the metaphase plate, suggesting a role for cohesin in mitosis (14). However, its mechanism was unknown. The same antibody failed to detect any hSMC1 at the interface between the two sister chromatids, which would be the predicted site for cohesin localization. To further address the mitotic role of human cohesin, we characterized the human cohesin complex containing hSMC1, hSMC3, hRAD21, and SA1/SA2 and performed detailed immunostaining and biochemical analyses of cohesin subcellular localization in human cells. Here we report that cohesin localizes at the spindle poles during mitosis and interacts with the nuclear mitotic apparatus protein (NuMA) and more weakly but specifically with dynein and beta -tubulin. Similar to NuMA, cohesin also interacts with the nuclear matrix during interphase. Further analysis showed that cohesin is required for mitotic spindle aster assembly in vitro. Our studies suggest a novel function of cohesin in mitotic spindle organization.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Lines and Cell Culture-- HeLa cells were grown in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10% fetal bovine serum, L-glutamate, and penicillin/streptomycin.

Synchronization of HeLa Cells-- HeLa cells were synchronized to the S and G2 phases by a double thymidine block, and to G1 phase by an additional nocodazole treatment as previously described (17). The DNA content profile from cells synchronized at each cell cycle stage was analyzed by a FACSCalibur (BD PharMingen). For FACS analysis, cells were fixed in 75% ethanol at -80 °C. Cells were then stained with 5 µg/ml propidium iodide in the presence of 300 µg/ml RNase A.

Antibodies-- Rabbit polyclonal antibodies were raised against recombinant polypeptides expressed in Escherichia coli corresponding to the middle and C-terminal domains of hSMC1 (amino acids 402-894 and 888-1233, respectively), the N-terminal domain of hSMC3 (amino acids 1-303), the N- and C-terminal domains of human SA1 designated as SA1N and SA1C (amino acids 1-230 and 1028-1258, respectively), the C-terminal domain of hRAD21 (amino acids 286-543), and the N terminus of NuMA (amino acids 1-307). Antibodies were affinity-purified with the same recombinant polypeptides purified and cross-linked to Affi-Gel (Bio-Rad) or expressed as glutathione S-transferase fusion proteins crosslinked to glutathione beads (Amersham Pharmacia Biotech.) with dimethyl pimelimidate (Sigma). Anti-Xenopus RAD21 (XRAD21) peptide antibody against the conserved C-terminal domain was kindly provided by Dr. Tatsuya Hirano at Cold Spring Harbor Laboratory (13). Anti-DNA ligase III antibody was generously provided by Dr. Thomas Lindahl at the Imperial Cancer Research Fund, United Kingdom. Anti-BRCA1 antibody was kindly provided by Dr. Ramin Shiekhattar at the Wistar Institute, Philadelphia, PA. Mouse monoclonal antibodies specific for NuMA (Calbiochem), for the dynein 70-kDa subunit (Sigma), and for beta -tubulin (Sigma) were also used for colocalization studies and Western blot analyses. Secondary antibodies included goat anti-rabbit IgG antibody conjugated with Cy3 (Jackson Laboratory), and donkey anti-mouse IgG antibody conjugated with fluorescein (Vector Laboratory).

Immunoprecipitation and Western Blot Analysis-- Large scale immunoprecipitation and peptide sequencing protocols used for the identification of hRAD21 are similar to those described (14). Coimmunoprecipitation was performed as previously described (14). The immunoprecipitated proteins were analyzed by SDS-PAGE and silver staining or transferred to nitrocellulose membrane and analyzed by Western blotting as described previously (14, 17). Western blots were developed by either colorimetric reaction (Promega) or enhanced chemiluminescence (ECL kit, Amersham Pharmacia Biotech).

Sucrose Gradient Ultracentrifugation-- To estimate sedimentation coefficient values, crude HeLa cell nuclear extracts in 0.4 M salt were subjected to 5-30% sucrose gradient centrifugation at 155,000 × g for 15 h with a SW50.1 rotor (Beckman Instruments). Each fraction was trichloroacetic acid-precipitated and analyzed by SDS-PAGE and Western blotting. Standard proteins bovine serum albumin (4.6 S), catalase (11.3 S), and ferritin (16.5 S) were run in the same gradient multiple times to confirm the linearity of the gradient.

Immunofluorescent Staining Analysis-- Immunofluorescent staining of cells was performed as described previously (14, 17). Immunofluorescent image analysis was performed using a Zeiss Axioplan 2 microscope with a Photometrics Sensys Camera. J/C Cittert iterative digital deconvolution was performed using the Zeiss KS 300 program. Alternatively, the analysis was carried out using an Olympus IX70 with the MagnaFire digital charge-coupled device camera system.

Cell Extraction-- In situ cell extraction was performed essentially as described (17). Cell extraction was performed either in situ on coverslips for immunostaining analysis or in test tubes for Western blot analysis. The same number of cells were used for the extraction in test tubes. Briefly, the cells were washed with phosphate-buffered saline and cytoskeleton (CSK) buffer (10 mM Pipes, pH 7.0, 100 mM NaCl, 300 mM sucrose, and 3 mM MgCl2). Cells were extracted using CSK buffer with 0.5% Triton-X for 5 min at 4 °C to remove soluble cytoplasmic proteins. Cells were then treated with an extraction buffer (42.5 mM Tris-HCl, pH 8.3, 8.5 mM NaCl, 2.6 mM MgCl2, 1% Tween 20, and 0.5% sodium deoxycholate) for 5 min at 4 °C to remove cytoskeletal proteins. The cells were subsequently treated with CSK buffer (containing 2 mM CaCl2 and 2 mM MgCl2), 0.5% Triton X, and 100 µg/ml DNase I (Worthington) for 30 min at 37 °C. The cells were then washed with 0.25 M ammonium sulfate in CSK. In a control sample, cells were treated with the same buffer without DNase I. Between each step, cells were centrifuged at 3,000 rpm, and the supernatant was recovered as the CSK extraction and DNase fractions. The pellet was washed twice in CSK buffer containing 0.5% Triton X, resuspended in SDS sample buffer, and subjected to SDS-PAGE and Western blot analysis. The experiments were repeated at least three times. The intensities of the protein bands in the Western blots from at least three experiments were quantitated by NIH IMAGE.

In Vitro Mitotic Aster Assembly Assay-- The in vitro aster assembly assay was performed using the protocol of Gaglio et al. (18-20). Briefly, HeLa cells were synchronized at mitosis as described above. Mitotic cells were collected by shake-off and incubated with 20 µg/ml cytochalasin B. Cells were then washed with phosphate-buffered saline and resuspended in KHM buffer (78 mM KCl, 50 mM Hepes, pH 7.0, 4 mM MgCl2, 2 mM EGTA, 1 mM dithiothreitol, and 0.2 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride) containing cytochalasin B at a concentration of ~3 × 107 cells/ml. Cells were Dounce-homogenized, and the crude extract was subjected to ultracentrifugation at 100,000 × g for 15 min. at 4 °C. The supernatant was collected, and a fraction of it was subjected to immunodepletion. Approximately 10-20 µg of either preimmune IgG purified with protein A beads, antigen affinity-purified anti-hSMC1, anti-hSMC3, anti-SA-1N, anti-hRAD21, or anti-BRCA1 antibody were coupled to protein A beads and incubated with 20 µl of mitotic extracts for 45 min at 4 °C. The beads were spun down, the supernatants were collected, and the depletion process was repeated. The final supernatants were passed through empty spin columns to remove any remaining beads. The supernatants were incubated for 60 min at 30 °C in the presence of 2.5 mM ATP and 10 µM taxol for the in vitro aster assembly. After the reaction, a small portion of each sample was dropped onto a coverslip and subjected to immunofluorescent staining with an antibody specific for beta -tubulin (Sigma) or co-stained with anti-NuMA antibody. The remaining portions of the samples were used for Western blot analysis to detect the presence of hSMC1, beta -tubulin, and NuMA. Mitotic asters assembled in a control reaction without immunodepletion were sedimented at 10,000 × g for 15 min at 4 °C as described (18), and the presence of NuMA and hSMC1 in the supernatant and pellet was analyzed by Western blot.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The hSMC1-hSMC3 Heterodimer Is in the Cohesin Complex in Both Interphase and Mitosis-- Previously, we identified the stable heterodimeric complex of hSMC1 and hSMC3 in human cells (14). Reciprocal coimmunoprecipitation of the endogenous hSMC1 and hSMC3 proteins from HeLa nuclear extracts indicates that the SMC molecules are engaged in a highly stable heterodimeric complex resistant to a mild denaturant (2 M guanidine) in an equimolar ratio in the absence of any other associated proteins (Fig. 1A). Because microinjection of an antibody against hSMC1 blocked the progression of metaphase in the previous study (14), we first wanted to determine whether hSMC1-hSMC3 is still in the cohesin complex in mitotic cells. Under the coimmunoprecipitation condition, including a 1 M salt wash, human cohesin containing hRAD21 and SA1/SA2 is coimmunopurified with antibody specific for hSMC1 (Fig. 1, B and C). The association of hRAD21 and SA1/SA2 with hSMC1-hSMC3, although resistant to the 1 M salt wash, is sensitive to 2 M guanidine unlike the interaction between hSMC1 and hSMC3 (Fig. 1A). Therefore, an hSMC1-hSMC3 heterodimer is a core subunit of cohesin, and hRAD21 and SA1/SA2 associate with it. The presence of hRad21 was also confirmed by peptide sequence analysis of the 115-kDa protein corresponding to hRAD21 (KINHL (amino acid 210) and KGGEADNLDEFLK (amino acid 410)) (GenBankTM accession number D38551) (21). The amounts of hRAD21 and SA1/SA2 coimmunoprecipitated with anti-hSMC1 antibody are comparable between S- and M-phase extracts, indicating that hSMC1-hSMC3 is part of cohesin during both S phase and mitosis (Fig. 1, B and C). Anti-SA1N antibody (directed against the N terminus of SA1) detected both SA1 and SA2, whereas anti-SA1C (against the C terminus) antibody detected a single protein species (SA1), consistent with the different C-terminal sequences in SA1 and SA2 (Fig. 1, C and D) (5). Because bovine SMC1 and SMC3 was found to be part of the recombination repair complex, RC-1 (22), the presence of DNA ligase III in the hSMC1 coimmunoprecipitation was also examined. DNA ligase III was not detected in our coimmunoprecipitation from HeLa nuclear extracts, indicating that the RC-1 repair complex represents a very minor complex in human cells (data not shown). Taken together, these results indicate that hSMC1-hSMC3 is in the cohesin complex in both S phase and mitotic cells at similar levels. The specificity of the antigen affinity-purified antibodies specific for hSMC1, hSMC3, hRAD21, and SA1N and SA1C was demonstrated by Western blot analysis using crude HeLa extracts from various cell cycle stages (14) as well as mitotic whole cell extracts (Fig. 1D).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 1.   Human cohesin, containing a hSMC1/hSMC3 heterodimer, SA1/SA2, and hRAD21 is a major complex containing hSMC1/hSMC3. A, reciprocal immunoprecipitation of the hSMC1/hSMC3 heterodimeric complex. Antibodies specific for hSMC1 and hSMC3 were used to immunoprecipitate the endogenous SMC proteins from HeLa nuclear extracts. Immunoprecipitates were washed with 2 M guanidine-HCl, and proteins remaining on antibody beads were visualized by silver staining. The polypeptides corresponding to hSMC1 and hSMC3 are indicated. The antibodies used for immunoprecipitation are indicated at the top. IgH, IgG heavy chain; M, molecular weight marker. B, coimmunoprecipitation of hRAD21 with anti-hSMC1 antibody. HeLa extracts from S phase (S) and M phase (M) were immunoprecipitated with an anti-hSMC1 antibody and washed with 1 M salt. The precipitated materials were subjected to Western blot analysis using an antibody specific for RAD21. Lanes 2 and 4 are input extracts (input) and lanes 1 and 3 are immunoprecipitated polypeptides (IP) as indicated at the top. C, coimmunoprecipitation of SA1/SA2 with an anti-hSMC1 antibody. The experiments were performed similar to B but probed with an anti-SA1N antibody. Lanes 1 and 2 are input extracts (input), and lanes 3 and 4 are the proteins immunoprecipitated (IP) with anti-hSMC1 antibody. Cell cycle stages of the extracts (S, S phase; M, M phase) are indicated at the top. Two protein species detected by an anti-SA1N antibody are indicated as SA1 and SA2. D, Western blot analysis of whole cell extracts from mitotic HeLa cells. The specificity of antibodies against the middle domain and the C-terminal domain of hSMC1 (lanes 1 and 2), the N terminus of hSMC3 (lane 3), SA1N (which detects both SA1 and SA2), and SA1C is shown. These antibodies were used in subsequent experiments.

Cohesin Localizes to Spindle Poles during Mitosis and Interacts with NuMA, Dynein, and beta -Tubulin-- Using the above antibodies, we next tested whether cohesin localizes to specific sites in mitotic cells. We performed a partial in situ extraction of soluble proteins for this purpose (CSK extraction, see "Experimental Procedures"). We found that a subpopulation of cohesin localizes to spindle poles in mitotic cells, both in metaphase and anaphase (Fig. 2). Spindle pole staining was detected using antibodies against hSMC1 (produced in two different rabbits), hSMC3, SA1N (which also recognizes SA2), and SA1C (Fig. 2 and data not shown). The corresponding preimmune antisera and antigen-depleted antibodies did not show spindle pole staining, indicating that the staining is antigen-specific (data not shown). The spindle pole localization was verified by co-staining with both beta - and gamma -tubulin antibodies (data not shown). Thus, cohesin is present at spindle poles during mitosis.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 2.   Human cohesin localizes to spindle poles in mitosis. Immunofluorescent staining of spindle poles with antibodies specific for hSMC1 and SA1N. DNA was visualized by DAPI staining. Cells were pre-extracted with CSK buffer. Mitotic spindle poles are indicated by white arrowheads. In merged images (panels 3 and 6), SA1 or hSMC1 (red) and DAPI (cyan) are shown.

Based on the above results, we next tested for potential interactions of cohesin with proteins that are known to localize to the spindle poles. We found that cohesin specifically interacts with NuMA. NuMA plays an important role in mitotic spindle organization in vivo and in vitro (20, 23). NuMA interacts with dynein/dynactin and beta -tubulin and is targeted to the mitotic spindle poles by the dynein/dynactin-dependent transport mechanism (23, 24). An anti-hSMC3 antibody co-precipitated NuMA from mitotic HeLa extracts, which is resistant to a 1 M salt wash (Fig. 3, lane 4). Neither the protein A beads alone nor the preimmune antibody precipitated NuMA (Fig. 3, lanes 2 and 3). Because NuMA interacts with dynein and beta -tubulin, cohesin interaction with these proteins was also tested. Anti-hSMC3 antibody coimmunoprecipitated dynein and beta -tubulin from mitotic extracts (Fig. 3, lanes 5-15). No dynein or beta -tubulin was precipitated with protein A beads alone or with preimmune IgG (lanes 6, 7, 9, 10, 13, and 14). In contrast to the NuMA interaction, however, these interactions were entirely sensitive to 1 M salt, indicating that the interaction is weaker and may be indirect (Fig. 3, lanes 8 and 15).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   The hSMC3 protein interacts with NuMA, dynein, and beta -tubulin in mitosis. Western blot analyses of anti-hSMC3 coimmunoprecipitation probed with anti-NuMA, anti-dynein, and anti-beta -tubulin antibodies. HeLa mitotic extracts were immunoprecipitated with an anti-hSMC3 antibody, and the precipitated material was subjected to multiple low salt washes and eluted with 1 M salt followed by 2 M guanidine-HCl. As indicated at the bottom, proteins eluted by each treatment (1 M salt and 2 M guanidine-HCl) were trichloroacetic acid-precipitated and subjected to Western blot analysis. As indicated at the top, protein A beads without an antibody (lanes 2, 6, 9, and 13) or preimmune IgG on beads (lanes 3, 7, 10, and 14) were incubated with the same extract and were treated in an identical manner. Lanes 1, 5, and 12, an input extract as a positive control for the Western blot.

The interaction of NuMA and cohesin was also examined in S phase (Fig. 4, A and B). Anti-hSMC1 antibody co-precipitated NuMA from both S and M phase extracts (Fig. 4A, lanes 5 and 6). In contrast, CNAP1 (hCAP-D2), a component of the condensin complex that is present abundantly in the mitotic cytoplasm as well as on chromosomes (17), failed to co-precipitate with hSMC1, demonstrating the specificity of the coimmunoprecipitation (Fig. 4A, lanes 9-12). Consistently, NuMA reciprocally coimmunoprecipitated hSMC1 from both S- and M-phase extracts (Fig. 4B). Furthermore, SA1/SA2, hRAD21, and NuMA co-precipitated each other in a 1 M salt-resistant manner (data not shown). Interestingly, among the multiple species of NuMA, only a subspecies of NuMA appears to tightly interact with cohesin (Fig. 3, compare lanes 1 and 4; Fig. 4A, compare lanes 1, 2, 5, and 6). The one that preferentially interacts with cohesin in a 1 M salt-resistant manner differs between S and M phases, a faster migrating species in S phase and a slower one in M phase (Fig. 4A, lanes 5 and 6). NuMA was shown to be hyperphosphorylated in a mitosis-specific manner by cdc2 kinase, which results in slower migration of the protein in SDS-PAGE (25). This phosphorylation was shown to be critical for the proper targeting of NuMA to spindle microtubules and is thus important for the function of NuMA in spindle organization (26). Therefore, our results strongly suggest that cohesin specifically interacts with NuMA localized at the spindle structure in mitosis (Fig. 3, lane 4; Fig. 4A, lane 6). However, the tight interaction was only seen with a subpopulation of each form of NuMA (Fig. 4A, compare 1 M salt and guanidine eluate), and the peak of NuMA in sucrose density gradient centrifugation did not coincide with that of cohesin, indicating that NuMA is not a component of cohesin (Fig. 4C). Taken together, the identified interaction of cohesin with the known spindle pole-associated protein NuMA, as well as weaker but specific interactions with dynein and beta -tubulin, further supports the observed localization of cohesin at the spindle poles.


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 4.   Human cohesin interacts with NuMA in both mitosis and interphase. A, Western blot analysis of anti-hSMC1 coimmunoprecipitation. HeLa extracts were immunoprecipitated with an anti-hSMC1 antibody and eluted with 1 M salt followed by 2 M guanidine-HCl. In addition to an input extract (positive control) (lanes 1, 2, and 9), 1 M salt (lanes 3, 4, and 10), 2 M guanidine eluate (lanes 5, 6, and 11), and the remaining beads (lanes 7, 8, and 12) as indicated at the top were subjected to Western blot analysis with anti-NuMA antibody (lanes 1-8) and anti-CNAP1 antibody (lanes 9-12). S, S-phase extract; M, M-phase extract; lanes 9-12, M-phase extract coimmunoprecipitation. Preferentially co-precipitated NuMA subspecies are indicated by arrowheads (lanes 5 and 6). B, reciprocal immunoprecipitation of hSMC1 with anti-NuMA antibody. Lanes 1 and 4, input; lanes 2 and 5, immunoprecipitated with protein A beads alone (no antibody); and lanes 3 and 6, immunoprecipitated with anti-NuMA antibody as indicated at the top. hSMC1 signal is indicated. Lanes 1-3, mitotic extract; lanes 4-6, S phase extract. C, Western blot analysis of fractions from 5 to 30% sucrose gradient fractionation of crude HeLa S phase extract with antibodies specific for hSMC1, NuMA, and RAD21. Fractions 1-11 represent the bottom to the top of the gradient. Input, input extract. The peaks of hRAD21 and NuMA are shown with brackets.

Human Cohesin Interacts with the Nuclear Matrix-- NuMA was shown to associate with the nuclear matrix during interphase (27). Because cohesin interacts with NuMA in interphase, we next tested whether cohesin also associates with the nuclear matrix. We performed serial extractions of cells on coverslips with detergent and DNase I to visualize the proteins tightly associated with the nuclear matrix (28) (Fig. 5). Completion of DNA digestion and extraction was monitored by the disappearance of DAPI staining (Fig. 5, panel 4). The results revealed that a significant amount of hSMC1 associates tightly with the nuclear matrix. Similar results were obtained with antibodies against hSMC3, hRAD21, and SA1/SA2 (data not shown). No significant difference was observed between the cells extracted with or without high salt after DNase I treatment. Thus, it is unlikely that the observed nuclear matrix localization is due to the precipitation of cohesin proteins. The nuclear matrix association of cohesin contrasts with the observation noted with condensin, the other SMC-containing complex, the nuclear localization of which was sensitive to DNase I treatment (17).


View larger version (82K):
[in this window]
[in a new window]
 
Fig. 5.   Human cohesin associates with the nuclear matrix during interphase. Immunofluorescent staining analysis of hSMC1 after serial in situ extraction of HeLa cells. The top panels show the localization of hSMC1 after each treatment using anti-hSMC1 antibody, and the bottom panels show DAPI. Each treatment is indicated at the top. The untreated panel shows the localization of hSMC1 before the extraction treatment (panel 1). Cells were treated with CSK and extraction buffers that remove soluble cytoplasmic proteins (panels 2 and 3). The cells were then treated with DNase I to remove DNA (panel 4).

We next performed the same experiments in a test tube. These extractions with salt and detergent as well as DNase I removed soluble cytoplasmic and nuclear proteins as well as DNA-associated proteins in a stepwise manner, leaving proteins that tightly associate with the nuclear matrix. Eluted material from each step was subjected to Western blot analysis with anti-hSMC1 antibody (Fig. 6A). We found three populations of hSMC1. The first population of hSMC1 eluted in the soluble fractions (Fig. 6A, CSK and Extraction, lanes 2 and 3). A second population of hSMC1 was co-eluted with DNA after DNase I digestion (Fig. 6A, lane 4). This elution was dependent on DNase I (Fig. 6A, lane 9). A third population of hSMC1 remained associated with the nuclear matrix (Fig. 6A, lane 5). In the same experiments, cytoplasmic dynein was removed in the first extraction while NuMA remained in the last nuclear matrix fraction, consistent with their subcellular localization (Fig. 6B). When extractions from S and G2 phase cells were compared, we found that cohesin dissociation from chromosomes is initiated in the G2 phase. In G2 phase, significantly less hSMC1 and hSMC3 were found in the DNA fraction compared with S phase, indicating that they are dissociating from chromosomes during G2 phase (Fig. 6C, compare lanes 4 and 9). Despite their dissociation from chromosomes, however, both hSMC1 and hSMC3 remain associated with the nuclear matrix (Fig. 6C, lane 10). Similar changes were observed with hRAD21 and SA1/SA2 (data not shown). Proper synchronization of cells to S and G2 phases was confirmed by FACS analysis (Fig. 6D). Importantly, at 7 h after release from the thymidine block (the prospective time point for G2 phase), cells were clearly in interphase and not in prophase (Fig. 6E). Therefore, this is different from the results in Xenopus embryos in which cohesin dissociation was shown to occur in prometaphase (6). This may reflect the differences in cell cycling between somatic and embryonic cells. Similar experiments with G1-synchronized cells revealed that cohesin associates with chromosomes, although at a lower level than in S phase, and with the nuclear matrix (data not shown). These results indicate that the association of cohesin with chromosomes is greatest in S phase and that its dissociation from chromosome begins during G2 phase, whereas a subpopulation remains associated with the nuclear matrix throughout interphase.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 6.   Association of human cohesin with chromosomes and the nuclear matrix during S and G2 phases. A, Western blot analysis of hSMC1 eluted by stepwise extractions of S phase-synchronized HeLa cells. Each treatment is indicated at the top. Lanes 6-10 show samples that were treated in an identical manner to the samples in lanes 1-5 except that lane 4 was treated with DNase I and lane 9 was treated with the same buffer without DNase I. B, Western blot analysis of extractions of dynein and NuMA. The same extracted samples as in A were analyzed with an antibody specific for dynein (lanes 1-5) and NuMA (lanes 6-10). The proteins are indicated by arrowheads. C, Western blot analysis of cohesin components in the extracted samples from S- and G2-phase cells. The same numbers of cells were treated in an identical manner, using cells synchronized at S phase (lanes 1-5) and G2 phase (lanes 6-10). Each treatment is indicated at the top. The same samples were probed with antibodies against hSMC1 and hSMC3 as indicated. D, DNA content analysis of HeLa cells after a double thymidine block. After the release from the second thymidine block, cells were harvested at different time points as indicated at the bottom and were subjected to FACS analysis. The cells harvested at 2 and 7 h after the release from thymidine correspond to S- and G2-phase cells used in C, respectively. The histograms show the fluorescence signal (x axis) versus the cell number (y axis). E, cells at 7 h after the thymidine release. Scale bar is 200 µm.

Cohesin Is Required for Mitotic Aster Assembly in Vitro-- Localization of human cohesin at the spindle poles raises the possibility that cohesin may function in the spindle organization during mitosis. To test this hypothesis, in vitro mitotic aster assembly was performed using mitotic HeLa extracts, and the effect of cohesin depletion was examined. In the control assay, NuMA and the major population of hSMC1 co-sedimented with assembled asters consistent with the localization of cohesin at the spindle poles in mitotic cells (Fig. 7A). The extracts were immunodepleted with comparable amounts of affinity-purified antibodies against hSMC1, hSMC3, SA1N, anti-BRCA1, or purified preimmune IgG prior to the assembly reaction. Depletion of hSMC1 from the extracts was confirmed by Western blot analysis (Fig. 7B). Anti-hSMC1-hSMC3, and SA1N antibodies efficiently depleted hSMC1, whereas preimmune IgG and anti-BRCA1 failed to deplete hSMC1. The in vitro aster assembly was carried out using these immunodepleted extracts (Fig. 7C). Aster assembly is ATP-dependent, because omitting ATP abolished any aster or visible microtubule formation (Fig. 7C, panel 1). While preimmune IgG-and anti-BRCA1 depletion had no significant effect on aster formation, depletion with the anti-hSMC1, anti-hSMC3, or anti-SA1N antibody severely inhibited aster assembly. Occasionally, we observed a few irregular, smaller asters and short microtubules (Fig. 7C, panels 4, 5, and 6). Anti-BRCA1 antibody was used for comparison because BRCA1 was previously shown to localize to spindle poles and to play a role in centrosome replication (29, 30). The control experiments with preimmune IgG and anti-BRCA1 antibody demonstrate that the effect of immunodepletion is cohesin-specific. The failure to assemble asters in the cohesin-depleted extracts was apparently not due to indirect depletion of NuMA or beta -tubulin, because the amounts of NuMA and beta -tubulin were comparable in the control and experimental extracts as assessed by Western blot analysis (Fig. 7D). This is consistent with the observed in vivo interaction, in which only a subpopulation of NuMA and beta -tubulin is involved in the interaction with cohesin (Figs. 3 and 4).


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 7.   Human cohesin is required for mitotic spindle aster assembly in vitro. A, Western blot analysis of sedimented asters. After the normal aster assembly reaction, assembled asters were sedimented and the pellet (lane 1) and supernatant (lane 2) were subjected to Western blot analysis with anti-NuMA or anti-hSMC1 antibody as indicated. B, Western blot analysis of immunodepleted HeLa mitotic extracts. Lane 1, input mitotic extract. In lanes 2-7 antibodies used to deplete the extracts are indicated at the top. Depleted extracts were subjected to Western blot analysis with anti-hSMC1 as indicated on the left. C, mitotic asters assembled in vitro with immunodepleted extracts stained with anti-beta -tubulin antibody. The same depleted extracts as in B were used for the assembly reaction. Panel 1, aster assembly reaction carried out in the absence of ATP. The antibodies used to deplete the extracts are indicated at the top of each panel. A representative aster for each depletion is shown. Scale bars are 4 µm. D, Western blot analysis for the presence of NuMA and beta -tubulin. Lane 1, input mitotic extract; lane 2, anti-hSMC1-depleted extract; lane 3, preimmuno-IgG-depleted extract. The extracts were probed with anti-NuMA and anti-beta -tubulin antibodies as indicated.

To quantify the efficiency of aster assembly in immunodepleted extracts, equal amounts of assembly reactions were spotted on coverslips and co-stained for beta -tubulin and NuMA. In an in vitro assay, NuMA localizes to the polar end of the spindles at the core of the spindle aster, which can be used as a marker for the mitotic aster (18-20). Mitotic extracts were immunodepleted with the preimmune IgG, anti-hSMC1, or anti-hRAD21 antibody (Fig. 8). Similar to antibodies against other cohesin components, anti-hRAD21 immunodepleted cohesin from mitotic extracts (Fig. 8A, lane 3). Two hundred beta -tubulin/NuMA-positive signals were examined on coverslips in areas randomly chosen under the microscope, and the number of asters with normal morphology was counted (see Fig. 8 legend for details). The average percentages of normal asters in depleted extracts are shown in Fig. 8B. In preimmune-depleted extracts, normal asters constituted more than 95% of beta -tubulin/NuMA-positive spots, whereas cohesin-depleted extracts showed less than 10% normal asters (Fig. 8B). Fig. 9 shows the typical assembly products by preimmune-depleted and cohesin-depleted extracts. While clusters of asters with bright beta -tubulin and NuMA staining at the central core were seen in the preimmune-depleted assembly similar to the undepleted control, only a few irregular spindles with weak beta -tubulin staining and associated NuMA signals were seen in cohesin-depleted extracts. Taken together, these results indicate that cohesin is required for mitotic aster formation in vitro.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 8.   Quantification of aster assembly. A, Western blot analysis of immunodepleted mitotic extracts. Extracts were depleted with preimmune IgG (lane 1), anti-hSMC1 (lane 2), and anti-hRAD21 (lane 3) antibodies as indicated at the top. The degree of cohesin depletion was checked by the presence of hSMC1 as indicated. B, the efficiency of aster assembly. The immunodepleted extracts from Fig. 8A were used to assemble asters in vitro. The same volumes of reaction mixtures were placed on coverslips and co-stained with anti-beta -tubulin and anti-NuMA antibodies (see Fig. 9 legend). We examined 200 beta -tubulin-positive NuMA spots and counted normal asters among them by randomly choosing areas on the coverslip under the microscope. This was repeated three times on multiple coverslips from two independent experiments. The criteria for normal asters in this experiment are: 1) distinct clustering of beta -tubulin at the center; 2) co-localization of beta -tubulin with NuMA; and 3) at least four spindles emanating from the aster in at least three different directions (see Fig. 9). Percentages of normal asters were averaged with standard deviation and are shown in the bar graph.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 9.   Co-staining of asters with anti-beta -tubulin and NuMA antibodies. Rabbit anti-NuMA antibody (A and E) and mouse anti-beta -tubulin antibody (C and G) were used for co-staining as indicated at the top. Merged images are shown (B, D, F, and H) with NuMA in red, beta -tubulin in green, and overlap in yellow. Upper panels are the assembly with preimmune-depleted extract, and the lower panels are with an anti-hRAD21-depleted extract as indicated on the left. Because the beta -tubulin staining of the normal asters in the preimmune-depleted extract assembly is so much brighter than that of the irregular asters in the cohesin-depleted extract assembly, the former image was exposed three times less than the latter to visualize asters clearly. D and H show a higher magnification of the individual asters indicated by white arrows in B and F. H is overexposed to visualize weak beta -tubulin and NuMA staining. Scale bars are 10 µm in B and F, and 4 µm in D and H.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Although cohesin in both yeast and metazoans appears to play a role in the establishment of sister chromatid cohesion after replication during S phase, there are differences regarding the timing of cohesin dissociation from chromosomes and cohesin function during mitosis. Namely, cohesin functions in sister chromatid cohesion until the onset of anaphase in yeast, whereas a majority of it dissociates from chromosomes prior to mitosis in metazoans. However, our previous antibody microinjection studies suggested that hSMC1 is still involved in the progression of mitosis, possibly in metaphase plate organization in human mitotic cells (14). Does cytoplasmic cohesin, which no longer interacts with chromosomes, play any role in mitotic chromosome organization? Our current study demonstrates the mitosis-specific localization of cohesin at the spindle poles and a specific interaction between cohesin and NuMA, a factor critical for spindle organization. Finally, we show that cohesin depletion inhibits mitotic spindle aster assembly in vitro. Based on these results, we propose that cohesin may play an additional role in mitotic chromosome organization by acting on mitotic spindle structures.

Localization of Cohesin at the Mitotic Spindle Poles and the Nuclear Matrix-- Analysis of the subcellular localization of a protein by using immunofluorescent staining has often proven to be valuable in deducing its potential function in the cell. It is important, however, to utilize multiple antibodies because staining patterns can vary significantly depending upon the antigen epitopes, especially for large and/or highly structured proteins. Thus, our criteria for determining specific protein localization are the following. 1) Western blot analysis shows highly specific reactivity to the target protein. 2) At least two different batches of antibodies exhibit the same staining pattern, preferably with antibodies against different domains of the same protein. 3) If the protein is in a complex, antibodies against other subunits exhibit the same staining pattern; and finally, 4) the protein biochemically interacts with other proteins that localize to the same place.

We first established the specificity of antibodies for the cohesin components by Western analysis against the crude HeLa extracts. The recent studies indicated that the non-SMC components of cohesin, SA1 and RAD21, localize to the interface between the two sister chromatids, particularly the centromeric region, during metaphase (5, 15, 16). However, our antibodies against all four cohesin components, including the anti-hSMC1 antibody previously used for antibody microinjection (14), failed to detect any specific localization of the endogenous cohesin components in this location. Instead, we found that a significant population of cohesin localizes to spindle poles. The spindle pole localization of cohesin was confirmed by staining with multiple antibodies against three of the cohesin subunits and was antigen-specific. Interestingly, a previous report demonstrated that hSMC1 interacts with hsHec1, which was shown to localize to the spindle poles (37). Consistent with the spindle pole localization, we observed in mitosis a strong interaction of cohesin with a subpopulation of NuMA, the largest species that most likely represents the mitosis-specific, hyperphosphorylated form (25, 26). Weaker interactions of cohesin with dynein and beta -tubulin, which may be indirectly mediated by NuMA, were also observed. Although our antibody against hRAD21 failed to stain the mitotic spindle poles, NuMA-coimmunoprecipitated hRAD21 from mitotic extracts and cohesin depletion by an anti-hRAD21 antibody had a similar inhibitory effect on mitotic aster assembly. Thus, the lack of staining is most likely due to epitope inaccessibility of our antibody. Consistent with this notion, hRad21 was recently observed at mitotic spindles using a different antibody (16).

In interphase cells, sequential extraction revealed that not all cohesin associates with DNA, but some is soluble while a third population associates with the nuclear matrix. Dissociation of all four cohesin components from chromosomes is initiated during G2 phase earlier than previously observed in a Xenopus system, which may be due to differences in cell cycling between somatic cells and embryos (6). Consistent with the nuclear matrix association, the interaction between cohesin and NuMA persists during interphase (25, 26). Although not well defined, the nuclear matrix has been implicated in molecule transport as well as in a higher order chromosome organization (31-33). Our results raise the interesting possibility that cohesin-mediated chromosome organization may occur in the context of the nuclear matrix. Consistent with this hypothesis, cohesin was reported to play a role in establishing the boundary elements at the HMR locus in S. cerevisiae (34). Boundary elements are thought to exert their function by interacting with the nuclear matrix (35, 36). Alternatively, the nuclear matrix-associated cohesin may constitute a separate population of cohesin, which may be dedicated to participation in spindle organization in mitosis.

The Possible Role of Cohesin in Mitotic Spindle Organization-- To determine the potential function of cohesin found at the spindle apparatus, an in vitro aster assembly assay was carried out using HeLa mitotic extracts. This assay was used previously to demonstrate the function of proteins localized at the spindle poles, such as NuMA, Eg5, and dynein in mitotic spindle organization (18-20, 23). These results were validated by the in vivo data in Xenopus (23). Using this assay, we demonstrated that mitotic aster assembly was inhibited in a cohesin depletion-specific manner. Aster assembly was inhibited by immunodepletion with an antibody against hSMC1, hSMC3, SA1/SA2, or hRAD21, but not with preimmune IgG, indicating that the cohesin complex is involved in the assembly of mitotic asters. Although BRCA1 was shown to localize to spindle poles and play an important role in centrosome replication (29, 30), immunodepletion using anti-BRCA1 antibody did not deplete cohesin and had no effect on mitotic spindle aster assembly, indicating that the inhibition of aster formation is cohesin-specific and not due to a nonspecific depletion effect of any protein at spindle poles. Furthermore, cohesin antibodies failed to co-deplete significant amounts of NuMA and beta -tubulin in our system, consistent with the fact that only a subpopulation of NuMA and beta -tubulin interacts with cohesin. This result indicates that the abolishment of aster assembly is not due to the lack of NuMA or beta -tubulin. This idea is further supported by the observation that NuMA is still associated with the irregularly shaped asters in the cohesin-depleted assembly reactions, indicating that depletion of cohesin does not affect NuMA localization. Rather, it is possible that cohesin is recruited to the spindle poles by NuMA. Because beta -tubulin staining of the irregular asters was much weaker, cohesin may be required for the assembly or maintenance of spindles. This effect is specific to cohesin and/or other factors that interact with and therefore are co-depleted with cohesin. We have preliminary evidence that cohesin may interact in a mitosis-specific manner with other factors that may be important partners for the mitotic function of cohesin.2 Further study is necessary to investigate the NuMA-cohesin interaction as well as whether cohesin interacts with other proteins important for mitotic spindle organization, such as the component(s) of centrosomes and/or pericentrosomal structures. Interestingly, the kinesin-related proteins KIF3A and 3B and their associated protein SMAP were previously reported to interact with hSMC3 (HCAP), also suggesting the potential function of cohesin in the context of the microtubule network (38). Although currently it is not clear how cohesin participates in mitotic spindle aster assembly, our results indicate the multifunctionality of cohesin in the cell.

    ACKNOWLEDGEMENTS

We thank Drs. T. Hirano, T. Lindahl, and R. Shiekhattar for kindly providing antibodies for XRAD21, DNA ligase III, and BRCA1, respectively. We thank Dr. C. Cooper for permission to call SB1.8 hSMC1. We extend similar thanks to Dr. Y. Takai for permission to refer to HCAP as hSMC3. We thank Dr. C. Hughes for use of a FACS machine, and H. Liu, M. Nomura, and S. Sandmeyer for access to the Zeiss microscope. We are grateful for critical reading of the manuscript by Drs. B. Hamkalo, S. Sandmeyer, M. Nomura, R. Steele, M. Waterman, and A. Ball.

    FOOTNOTES

* This work was supported in part by a March of Dimes Basil O'Connor Scholarship and National Institutes of Health Grant GM59150 (to K. Y.)The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Present address: Dept. of Pharmacology, Tohoku University School of Medicine, 2-1 Seiryomachi Aobaku, Sendai 980-8575, Japan.

|| Formerly a Leukemia and Lymphoma Society Special Fellow and currently a Scholar of the Leukemia and Lymphoma Society. To whom correspondence should be addressed. Dept. of Biological Chemistry, College of Medicine, 240D Med. Sci. I, University of California, Irvine, CA 92697-1700. Tel.: 949-824-8215; Fax: 949-824-2688; E-mail: kyokomor@uci.edu.

Published, JBC Papers in Press, October 4, 2001, DOI 10.1074/jbc.M103364200

2 J. A. Schmiesing and K. Yokomori, unpublished data.

    ABBREVIATIONS

The abbreviations used are: SMC, structural maintenance of chromosomes; SA1, stromal antigen 1; SA2, stromal antigen 2; hRAD21, human RAD21 protein; hSMC, human SMC protein; NuMA, nuclear mitotic apparatus protein; FACS, fluorescence-activated cell sorter; SA1N, N-terminal domain of SA1; SA1C, C-terminal domain of SA1; SDS-PAGE, SDS-polyacrylamide gel electrophoresis; CSK, cytoskeleton; Pipes, 1,4-piperazinediethanesulfonic acid; DAPI, 4,6-diamidino-2-phenylindole.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Guacci, V., Koshland, D., and Strunnikov, A. (1997) Cell 91, 47-57[CrossRef][Medline] [Order article via Infotrieve]
2. Michaelis, C., Ciosk, R., and Nasmyth, K. (1997) Cell 91, 35-45[CrossRef][Medline] [Order article via Infotrieve]
3. Toth, A., Ciosk, R., Uhlmann, F., Galova, M., Schleiffer, A., and Nasmyth, K. (1999) Genes Dev. 13, 320-333[Abstract/Free Full Text]
4. Nasmyth, K., Peters, J.-M., and Uhlmann, F. (2000) Science 288, 1379-1384[Abstract/Free Full Text]
5. Losada, A., Yokochi, T., Kobayashi, R., and Hirano, T. (2000) J. Cell Biol. 150, 405-416[Abstract/Free Full Text]
6. Sumara, I., Vorlaufer, E., Gieffers, C., Peters, B. H., and Peters, J.-M. (2000) J. Cell Biol.
7. Tomonaga, T., Nagao, K., Kawasaki, Y., Furuya, K., Murakami, A., Morishita, J., Yuasa, T., Sutani, T., Kearsey, S. E., Uhlmann, F., Nasmyth, K., and Yanagida, M. (2000) Genes Dev. 14, 2757-2770[Abstract/Free Full Text]
8. Birkenbihl, R. P., and Subramani, S. (1992) Nucleic Acids Res. 25, 6605-6611
9. Uhlmann, F., Wernic, D., Poupart, M.-A., Koonin, E. V., and Nasmyth, K. (2000) Cell 103, 375-386[CrossRef][Medline] [Order article via Infotrieve]
10. Tanaka, T., Cosma, M. P., Wirth, K., and Nasmyth, K. (1999) Cell 98, 847-858[CrossRef][Medline] [Order article via Infotrieve]
11. Blat, Y., and Kleckner, N. (1999) Cell 98, 249-259[CrossRef][Medline] [Order article via Infotrieve]
12. Megee, P. C., Mistrot, C., Guacci, V., and Koshland, D. (1999) Mol. Cell 4, 445-450[CrossRef][Medline] [Order article via Infotrieve]
13. Losada, A., Hirano, M., and Hirano, T. (1998) Genes Dev. 12, 1986-1997[Abstract/Free Full Text]
14. Schmiesing, J. A., Ball, A. R., Gregson, H. C., Alderton, J., Zhou, S., and Yokomori, K. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 12906-12911[Abstract/Free Full Text]
15. Waizenegger, I. C., Hauf, S., Meinke, A., and Peters, J.-M. (2000) Cell 103, 399-410[CrossRef][Medline] [Order article via Infotrieve]
16. Hoque, M. T., and Ishikawa, F. (2001) J. Biol. Chem. 276, 5059-5067[Abstract/Free Full Text]
17. Schmiesing, J. A., Gregson, H. C., Zhou, S., and Yokomori, K. (2000) Mol. Cell. Biol. 20, 6996-7006[Abstract/Free Full Text]
18. Gaglio, T., Dionnne, M. A., and Compton, D. A. (1997) J. Cell Biol. 138, 1055-1066[Abstract/Free Full Text]
19. Gaglio, T., Saredi, A., Bingham, J. B., Hasbani, M. J., Gill, S. R., Schroer, T. A., and Compton, D. A. (1996) J. Cell Biol. 135, 399-414[Abstract/Free Full Text]
20. Gaglio, T., Saredi, A., and Compton, D. A. (1995) J. Cell Biol. 131, 693-708[Abstract/Free Full Text]
21. Nomura, N., Nagase, T., Miyajima, N., Sazuka, T., Tanaka, A., Sato, S., Seki, N., Kawarabayashi, Y., Ishikawa, K., and Tabata, S. (1994) DNA Res. 1, 223-229[Abstract]
22. Jessberger, R., Riwar, B., Baechtold, H., and Akhmedov, A. T. (1996) EMBO J. 15, 4061-4068[Medline] [Order article via Infotrieve]
23. Merdes, A., Ramyar, K., Vechio, J. D., and Cleveland, D. W. (1996) Cell 87, 447-458[CrossRef][Medline] [Order article via Infotrieve]
24. Merdes, A., Heald, R., Samejima, K., Earnshaw, W. C., and Cleveland, D. W. (2000) J. Cell Biol. 149, 851-861[Abstract/Free Full Text]
25. Hsu, H.-L., and Yeh, N.-H. (1996) J. Cell Sci. 109, 277-288[Abstract]
26. Compton, D. A., and Luo, C. (1995) J. Cell Sci. 108, 621-633[Abstract]
27. Lydersen, B. K., and Pettijohn, D. E. (1980) Cell 22, 489-499[CrossRef][Medline] [Order article via Infotrieve]
28. Fey, E. G., Wan, K. M., and Penman, S. (1984) J. Cell Biol. 98, 1973-1984[Abstract/Free Full Text]
29. Hsu, L. C., and White, R. L. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 12983-12988[Abstract/Free Full Text]
30. Xu, X., Weaver, Z., Linke, S. P., Li, C., Gotay, J., Wang, X. W., Harris, C. C., Ried, T., and Deng, C. X. (1999) Mol. Cell 3, 389-395[CrossRef][Medline] [Order article via Infotrieve]
31. de Belle, I., Cai, S., and Kohwi-Shigematsu, T. (1998) J. Cell Biol. 141, 335-348[Abstract/Free Full Text]
32. Pederson, T. (2000) Mol. Biol. Cell 11, 799-805[Abstract/Free Full Text]
33. Zhao, K., Wang, W., Rando, O. J., Xue, Y., Swiderek, K., Kuo, A., and Crabtree, G. R. (1998) Cell 95, 625-636[CrossRef][Medline] [Order article via Infotrieve]
34. Donze, D., Adams, C. R., Rine, J., and Kamakaka, R. T. (1999) Genes Dev. 13, 698-708[Abstract/Free Full Text]
35. Gerasimova, T. I., and Corces, V. G. (1998) Cell 92, 511-521[CrossRef][Medline] [Order article via Infotrieve]
36. Udvardy, A. (1999) EMBO J. 18, 1-8[CrossRef][Medline] [Order article via Infotrieve]
37. Zheng, L., Chen, Y., and Lee, W.-H. (1999) Mol. Cell. Biol. 19, 5417-5428[Abstract/Free Full Text]
38. Shimizu, K., Shirataki, H., Honda, T., Minami, S., and Takai, Y. (1998) J. Biol. Chem. 273, 6591-6594[Abstract/Free Full Text]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
X. Kong, S. K. Mohanty, J. Stephens, J. T. Heale, V. Gomez-Godinez, L. Z. Shi, J.-S. Kim, K. Yokomori, and M. W. Berns
Comparative analysis of different laser systems to study cellular responses to DNA damage in mammalian cells
Nucleic Acids Res., May 1, 2009; 37(9): e68 - e68.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
X. Kong, A. R. Ball Jr., E. Sonoda, J. Feng, S. Takeda, T. Fukagawa, T. J. Yen, and K. Yokomori
Cohesin Associates with Spindle Poles in a Mitosis-specific Manner and Functions in Spindle Assembly in Vertebrate Cells
Mol. Biol. Cell, March 1, 2009; 20(5): 1289 - 1301.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. W. Wong and G. Blobel
Cohesin subunit SMC1 associates with mitotic microtubules at the spindle pole
PNAS, October 7, 2008; 105(40): 15441 - 15445.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
G. Stanvitch and L. L. Moore
cin-4, a Gene With Homology to Topoisomerase II, Is Required for Centromere Resolution by Cohesin Removal From Sister Kinetochores During Mitosis
Genetics, January 1, 2008; 178(1): 83 - 97.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. L. Parish, J. Rosa, X. Wang, J. M. Lahti, S. J. Doxsey, and E. J. Androphy
The DNA helicase ChlR1 is required for sister chromatid cohesion in mammalian cells
J. Cell Sci., December 1, 2006; 119(23): 4857 - 4865.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Assmann, M. R. Alborghetti, M. E. R. Camargo, and J. Kobarg
FEZ1 Dimerization and Interaction with Transcription Regulatory Proteins Involves Its Coiled-coil Region
J. Biol. Chem., April 14, 2006; 281(15): 9869 - 9881.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Jia, L. Barbier, H. Stuart, M. Amraei, S. Pelech, J. W. Dennis, P. Metalnikov, P. O'Donnell, and I. R. Nabi
Tumor Cell Pseudopodial Protrusions: LOCALIZED SIGNALING DOMAINS COORDINATING CYTOSKELETON REMODELING, CELL ADHESION, GLYCOLYSIS, RNA TRANSLOCATION, AND PROTEIN TRANSLATION
J. Biol. Chem., August 26, 2005; 280(34): 30564 - 30573.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J.-S. Kim, T. B. Krasieva, H. Kurumizaka, D. J. Chen, A. M. R. Taylor, and K. Yokomori
Independent and sequential recruitment of NHEJ and HR factors to DNA damage sites in mammalian cells
J. Cell Biol., August 1, 2005; 170(3): 341 - 347.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
W. S. Lam, X. Yang, and C. A. Makaroff
Characterization of Arabidopsis thaliana SMC1 and SMC3: evidence that AtSMC3 may function beyond chromosome cohesion
J. Cell Sci., July 15, 2005; 118(14): 3037 - 3048.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-C. Huang, R. Jagadeeswaran, E. S. Liu, and E. J. Benz Jr.
Protein 4.1R, a Microtubule-associated Protein Involved in Microtubule Aster Assembly in Mammalian Mitotic Extract
J. Biol. Chem., August 13, 2004; 279(33): 34595 - 34602.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
T. M. Geiman, U. T. Sankpal, A. K. Robertson, Y. Chen, M. Mazumdar, J. T. Heale, J. A. Schmiesing, W. Kim, K. Yokomori, Y. Zhao, et al.
Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery
Nucleic Acids Res., May 17, 2004; 32(9): 2716 - 2729.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. T. Parra, A. Viera, R. Gomez, J. Page, R. Benavente, J. L. Santos, J. S. Rufas, and J. A. Suja
Involvement of the cohesin Rad21 and SCP3 in monopolar attachment of sister kinetochores during mouse meiosis I
J. Cell Sci., March 1, 2004; 117(7): 1221 - 1234.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. P. Bermudez, Y. Maniwa, I. Tappin, K. Ozato, K. Yokomori, and J. Hurwitz
The alternative Ctf18-Dcc1-Ctf8-replication factor C complex required for sister chromatid cohesion loads proliferating cell nuclear antigen onto DNA
PNAS, September 2, 2003; 100(18): 10237 - 10242.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-S. Kim, T. B. Krasieva, V. LaMorte, A. M. R. Taylor, and K. Yokomori
Specific Recruitment of Human Cohesin to Laser-induced DNA Damage
J. Biol. Chem., November 15, 2002; 277(47): 45149 - 45153.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/50/47575    most recent
M103364200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gregson, H. C.
Right arrow Articles by Yokomori, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gregson, H. C.
Right arrow Articles by Yokomori, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement